Table 2.
Univariate analysis for overall survival (OS) of stage IIIC patients with endometrial cancer.
| Variables | Stage IIIC1 | Stage IIIC2 | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Age, yrs | ||||
| 18–60 | Reference | Reference | ||
| >60 | 2.017 (1.762–2.308) | <0.001 | 1.778 (1.513–2.090) | <0.001 |
| Race | ||||
| White | Reference | Reference | ||
| Black | 1.688 (1.443–1.974) | <0.001 | 1.650 (1.372–1.985) | <0.001 |
| Others | 0.634 (0.497–0.808) | <0.001 | 0.842 (0.660–1.074) | 0.166 |
| Marital status | ||||
| Married | Reference | Reference | ||
| Others | 1.574 (1.387–1.785) | <0.001 | 1.549 (1.333–1.800) | <0.001 |
| Grade | ||||
| I+II | Reference | Reference | ||
| III+IV | 3.414 (2.930–3.977) | <0.001 | 3.321 (2.706–4.077) | <0.001 |
| Others | 2.027 (1.676–2.452) | <0.001 | 2.170 (1.680–2.804) | <0.001 |
| Histology | ||||
| Endometrioid | Reference | Reference | ||
| Serous | 2.534 (2.135–3.009) | <0.001 | 2.277 (1.881–2.757) | <0.001 |
| Others | 2.616 (2.290–2.988) | <0.001 | 2.131 (1.802–2.520) | <0.001 |
| Chemotherapy | ||||
| Yes | Reference | Reference | ||
| No/unknown | 1.694 (1.503–1.911) | <0.001 | 1.701 (1.468–1.970) | <0.001 |
| Radiotherapy | ||||
| Yes | Reference | Reference | ||
| No/unknown | 1.959 (1.729–2.219) | <0.001 | 1.753 (1.507–2.039) | <0.001 |